Get started
Author

Xiyuan Ji

Observed name: Xiyuan (Angel) Ji
ORCID: 0009-0007-3654-8253
Observed ORCID: 0009-0007-3654-8253
OpenAlex ID: A5019843130
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms
2026 · Jennifer W. Carlisle, Katherine O'Reilly, et al. · JCO Oncology Practice · 2
Adjuvant immunotherapy following upfront surgery for stage II–III triple-negative breast cancer: A National Cancer Database Study.
2026 · Madison T. Canning, Xiyuan (Angel) Ji, et al. · Journal of Clinical Oncology · 1
Implementation of tarlatamab treatment for small cell lung cancer using an outpatient care program.
2025 · Jennifer W. Carlisle, Katherine O'Reilly, et al. · Journal of Clinical Oncology · 1
PDF
Antibody-drug conjugate (ADC) after ADC: Predicting survival in patients with HER2-low metastatic breast cancer with lung metastasis using artificial intelligence (AI) and radiomics.
2026 · Rishi Dakarapu, Melissa Oye, et al. · Journal of Clinical Oncology
Trends in immunotherapy use and survival outcomes by metastatic pattern in metastatic triple-negative breast cancer.
2026 · Michael Schwartz, Xiyuan (Angel) Ji, et al. · Journal of Clinical Oncology
Social determinants of health and baseline blood biomarkers are associated with immunotherapy response in leukemia patients 3145
2025 · Xiyuan Ji, Nathan Denlinger, et al. · The Journal of Immunology
PDF
Works count: 6
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type